Thursday, May 02, 2019 9:53:44 PM
Its been quite awhile since I have posted. Still here, still holding strong. Still think we are under-valued but sometimes stocks don't move when they should, but with enough time they eventually get to where they should be (market can sometimes be irrational for longer than we like)
I did want to address today's form 4s and likely a few others like it that will come so people dont start to attack the timing and overplay the sale.
Aaron was awarded RSUs which 1/3 vest on each year anniversary. The form clearly shows that he was awarded the shares 5/1/2018 so they the first thrid would vest now. When they vest, it means you immediately owe ordinary income taxes (no different than if a cash bonus was received). Most executives and directors would have a plan in place that would have the company automatically sell a set percent of shares that cover taxes and that would be witheld from the sale and paid to the IRS by the company on his behalf. This is one of the few times similar to a 10b-1 plan that you can have a sale regardless of whether there is material info or not as it is set as a rule. Anytime I vest shares or have to exercise options, auto-sell and withhold taxes so I dont get stuck with a tax bill and then not in an open window to sell shares to cover it.
That is why you see he acquired shares and then you see he disposed of a sub-set which should be around 40% or so that is the tax exposure. This is automatic and typical. Aaron didn't decide to randomly sell. He had to have a form 4 update to recognize his vesting of shares and that would auto trigger the corresponding tax sale without any action from him. He didnt pick the day to sell - it is tied to whenever the shares vest. So I would imagine there will be other shares in different months (perhaps based on hire date) that when RSUs vest you will see an offsetting sale. Just like when they have to exercise options. That is very different insider selling than a random sale (when you just see a disposed line but no original acquired line too).
Also people keep pointing that such as such sold all of their shares etc. Keep in mind, we dont see all their shares. They have tons of shares and options that are either time based vesting or milestone based vesting that only show up against them when triggered. So you might think someone had 200K shares and sold all 200K and be like wow. But in reality that person may know they control another 1.2M shares that you wouldn't see and so in their mind they sold 15%. So trying to interpret true intent of insider sales is very tough. Last example - it was clear based on the company RRR modeling that they were more confident than even some of us on the success of the trial - yet many of them sold prior to results (because it is just prudent if you have super material anount of shares and everything tied together) but clearly history showed they weren't bearish so think how many times FFF misinterpreted their selling to mean results would be bad.
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM